Language selection

Government of Canada / Gouvernement du Canada

Search

Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines.: HP5-142/1-2022E-PDF ; HP5-142/2-2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.914912&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
TitleRecommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines.
Publication typeMonograph
Language[English]
Other language editions[French]
Later editionRecommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines.
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Recommandations sur l'utilisation des vaccins à ARNm bivalents contre la COVID-19 contenant le variant Omicron.
  • At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI).
  • Includes bibliographical references (pages 17-22).
Publishing information
  • Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, September 1, 2022.
  • ©2022
Description1 online resource (27 pages) + 1 summary (6 pages)
ISBN9780660452487 9780660452494
Catalogue number
  • HP5-142/1-2022E-PDF
  • HP5-142/2-2022E-PDF
Departmental catalogue number220386 (report) 220388 (summary)
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: